NAFDAC Seeks To Implement Pharmaceutical Traceability Strategy
The National Agency for Food and Drug Administration and Control (NAFDAC) has made a vow to confront the menace of substandard and falsified medicines in the country by implementing a pharmaceutical traceability strategy with a view to safeguarding the health of the Nigerian populace.
The Director General, of the Agency, Prof. Mojisola Adeyeye, who dropped the hint at the Traceability workshop in Port Harcourt, Rivers State, said the onerous task of safeguarding the health of the nation is daunting in the face of the chaotic drug distribution system currently existing in Nigeria.
She emphasised that the falsification and diversion of health commodities carry very serious health and economic consequences.
In a statement signed by the NAFDAC Resident Media Consultant in Lagos, Mr. Sayo Akintola, Adeyeye reiterated that NAFDAC had developed a 5-Year Traceability Implementation plan in line with the objectives of the Nigeria Pharmaceutical Traceability Strategy to achieve supply chain visibility and strengthen interventions against substandard and falsified medicines by the end of her second term.
She said the development, gazetting, and dissemination of the Traceability of Pharmaceutical products Regulations is essential for the adoption and enforcement of the provisions of the Nigeria Pharmaceutical Traceability Strategy.
The Regulation, accompanied by guidelines and compliance requirements would provide a legal framework to support advocacy for stakeholders to implement traceability in the distribution of pharmaceuticals or supply chains.
Read Also: N95bn Worth Of Unregistered Pharmaceutical Products Destroyed By NAFDAC
Further, Adeyeye noted that the participation of relevant stakeholders during the drafting of the Traceability Regulation is important to ensure understanding among stakeholders of the provisions and to welcome feedback, with the goal of improving compliance.
A major achievement in the direction of reducing the incidence of Substandard and Falsified medicines in the country was the hosting of the second Africa GSI Traceability Conference on Healthcare in Lagos in September 2019.
The Conference attracted Medicines Regulatory Agencies from about twenty-five countries in Africa, as well as other stakeholder partners from the Americas and Europe. The Agency is already on a five-year roadmap to establishing a culture of Track & Trace with regard to pharmaceutical products.
With this, Adeyeye said that medicines and medical devices can be monitored throughout the supply chain from manufacturing to the end user, the patient, adding that the Agency has developed a roadmap to this effect which has been approved by the Honourable Minister of Health.
She disclosed that the traceability strategy document was the outcome of the year’ (1919/2020) work by NAFDAC in collaboration with the Ministry of Health, USAID, and GS1 Technologies.
The NAFDAC Traceability Office. governance and current funding were subsequently supported by international partners such as USAID, World Bank, World Health Organisation; Bill and Melinda Gates Foundation, and Global Fund. All these have resulted in an enabling environment for the implementation of the track and trace of medical commodities using global standards.
As she described the benefits of implementing pharmaceutical traceability as enormous, Adeyeye said traceability would provide visibility of medicines from plant to patient to promote trust in the pharmaceutical sector and healthcare system.